Paul Maroni, MD
Urology · Aurora, CONPI 1235199688
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. BK Medical Holding Company Inc. accounts for 62.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,149 and has fallen 91.4% since, to $185 in 2025.
Across 27 payments — averaging $161.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- BK Medical Holding Company Inc.$3K
- Intuitive Surgical$786
- Boston Scientific$277
- Astellas Pharma US Inc$179
- EDAP Technomed Inc$109
- Merck$87
- plus $185 from 4 others
Across 50 payments — averaging $4589.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dendreon Pharmaceuticals LLC$167K
- Progenics Pharmaceuticals, Inc.$33K
- Astellas Pharma Global Development$30K
What the payments were for
- Speaking & faculty fees$2,50057%
- Travel & lodging$61714%
- Food & beverage$1,25729%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| BK Medical Holding Company Inc. | 4 | $2,750 |
| Intuitive Surgical | 8 | $786 |
| Boston Scientific | 4 | $277 |
| Astellas Pharma US Inc | 3 | $179 |
| EDAP Technomed Inc | 1 | $109 |
| Merck | 1 | $87 |
| Blue Earth Diagnostics | 1 | $81 |
| Mimedx Group, Inc. | 2 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Olympus America Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,374 in reported general payments places this provider in the 60th percentile of 225 urology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $2,540 |
| Solifenacin Succinate | 44 | $1,950 |
| Tamsulosin Hcl | 64 | $973 |
| Finasteride | 34 | $620 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 44 | $501 |
| Oxybutynin Chloride | 35 | $203 |
| CefuroximeCefuroxime Axetil | 79 | $193 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $67 |
| Diclofenac Potassium | 13 | $57 |
| Sildenafil Citrate | 13 | $53 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $37 |
| Levofloxacin | 31 | $25 |
| Diazepam | 15 | $23 |
Paid to pharmacies, not to this prescriber.
Other urology in Aurora
- Janet KukrejaAurora$39K
- Kirk RedgerAurora$24K
- David StraussAurora$16K
- Kerri ThurmonAurora$16K
- Brian FlynnAurora$12K
- Lawrence KarshDenver$706K
- Alexandra RogersLafayette$476K
- Derek ZukoskyGolden$442K
- James McBrideDurango$234K
- Damian SorceParker$224K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.